These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 26115722)
1. Eight proteins play critical roles in RCC with bone metastasis via mitochondrial dysfunction. Wang J; Zhao X; Qi J; Yang C; Cheng H; Ren Y; Huang L Clin Exp Metastasis; 2015 Aug; 32(6):605-22. PubMed ID: 26115722 [TBL] [Abstract][Full Text] [Related]
2. Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases. Pan T; Fong EL; Martinez M; Harrington DA; Lin SH; Farach-Carson MC; Satcher RL Cancer Lett; 2015 Aug; 365(1):89-95. PubMed ID: 26004343 [TBL] [Abstract][Full Text] [Related]
3. Autocrine and paracrine STIP1 signaling promote osteolytic bone metastasis in renal cell carcinoma. Wang J; You H; Qi J; Yang C; Ren Y; Cheng H Oncotarget; 2017 Mar; 8(10):17012-17026. PubMed ID: 28199984 [TBL] [Abstract][Full Text] [Related]
4. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice. Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601 [TBL] [Abstract][Full Text] [Related]
5. Co-existence of epithelioid and fibroblastoid subsets in a sarcomatoid renal carcinoma cell line revealed by clonal studies. Hsieh CH; Chen HC; Chang YH; Pang ST; Kuo ML; Chuang CK; Liao SK Anticancer Res; 2013 Nov; 33(11):4875-89. PubMed ID: 24222125 [TBL] [Abstract][Full Text] [Related]
6. C-met inhibition blocks bone metastasis development induced by renal cancer stem cells. D'Amico L; Belisario D; Migliardi G; Grange C; Bussolati B; D'Amelio P; Perera T; Dalmasso E; Dalle Carbonare L; Godio L; Comoglio P; Trusolino L; Ferracini R; Roato I Oncotarget; 2016 Jul; 7(29):45525-45537. PubMed ID: 27322553 [TBL] [Abstract][Full Text] [Related]
7. Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in a p-AKT-dependent manner. Jiang XL; Zhang Y; Tan B; Luo CL; Wu XH Neoplasma; 2014; 61(4):416-23. PubMed ID: 24645843 [TBL] [Abstract][Full Text] [Related]
8. A bone-seeking clone exhibits different biological properties from the ACHN parental human renal cell carcinoma in vivo and in vitro. Wang J; Chen A; Yang C; Zeng H; Qi J; Guo FJ Oncol Rep; 2012 Apr; 27(4):1104-10. PubMed ID: 22139406 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage. Zhu M; Li Y; Zhou Z Biochem Biophys Res Commun; 2017 Oct; 492(3):373-378. PubMed ID: 28847725 [TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers. Sun CY; Zang YC; San YX; Sun W; Zhang L Saudi Med J; 2010 May; 31(5):525-32. PubMed ID: 20464042 [TBL] [Abstract][Full Text] [Related]
12. Cadherin-11 regulates the metastasis of Ewing sarcoma cells to bone. Hatano M; Matsumoto Y; Fukushi J; Matsunobu T; Endo M; Okada S; Iura K; Kamura S; Fujiwara T; Iida K; Fujiwara Y; Nabeshima A; Yokoyama N; Fukushima S; Oda Y; Iwamoto Y Clin Exp Metastasis; 2015 Aug; 32(6):579-91. PubMed ID: 26092671 [TBL] [Abstract][Full Text] [Related]
13. Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues. Perego RA; Bianchi C; Corizzato M; Eroini B; Torsello B; Valsecchi C; Di Fonzo A; Cordani N; Favini P; Ferrero S; Pitto M; Sarto C; Magni F; Rocco F; Mocarelli P J Proteome Res; 2005; 4(5):1503-10. PubMed ID: 16212400 [TBL] [Abstract][Full Text] [Related]
14. [Bone metastasis by renal cell carcinoma. Importance of calcium and calcium-sensing receptor]. Brenner W; Haber T; Junker K; Roos F; Thüroff JW Urologe A; 2015 Jun; 54(6):839-43. PubMed ID: 25503898 [TBL] [Abstract][Full Text] [Related]
15. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells. Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585 [TBL] [Abstract][Full Text] [Related]
16. Pathway analysis of kidney cancer using proteomics and metabolic profiling. Perroud B; Lee J; Valkova N; Dhirapong A; Lin PY; Fiehn O; Kültz D; Weiss RH Mol Cancer; 2006 Nov; 5():64. PubMed ID: 17123452 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma. Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190 [TBL] [Abstract][Full Text] [Related]
18. Oral naftopidil suppresses human renal-cell carcinoma by inducing G(1) cell-cycle arrest in tumor and vascular endothelial cells. Iwamoto Y; Ishii K; Sasaki T; Kato M; Kanda H; Yamada Y; Arima K; Shiraishi T; Sugimura Y Cancer Prev Res (Phila); 2013 Sep; 6(9):1000-6. PubMed ID: 23901046 [TBL] [Abstract][Full Text] [Related]
19. Significance of COX-2 expression in human renal cell carcinoma cell lines. Chen Q; Shinohara N; Abe T; Watanabe T; Nonomura K; Koyanagi T Int J Cancer; 2004 Mar; 108(6):825-32. PubMed ID: 14712483 [TBL] [Abstract][Full Text] [Related]